Oncolytics Bio (ONC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,352 | 14,626 | 15,303 | 15,942 | 19,598 |
| Receivables | 54 | 72 | 89 | 68 | 104 |
| Other current assets | 0 | 1,024 | 1,220 | 980 | 1,092 |
| TOTAL | $14,051 | $18,896 | $18,487 | $18,875 | $22,913 |
| Non-Current Assets | |||||
| PPE Net | 1,006 | 1,078 | 1,215 | 1,312 | 1,349 |
| TOTAL | $1,006 | $1,078 | $1,215 | $1,312 | $1,349 |
| Total Assets | $15,057 | $19,974 | $19,702 | $20,187 | $24,262 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,201 | 1,331 | 779 | 1,087 | 3,427 |
| Accrued Expenses | 2,977 | 3,954 | 4,169 | 3,705 | 3,495 |
| Other current liabilities | 199 | 982 | 530 | 1,618 | 489 |
| TOTAL | $7,655 | $6,558 | $5,768 | $6,687 | $7,662 |
| Non-Current Liabilities | |||||
| TOTAL | $7,287 | $7,327 | $7,440 | $7,517 | $7,543 |
| Total Liabilities | $14,942 | $13,885 | $13,208 | $14,204 | $15,205 |
| Shareholders' Equity | |||||
| Common Shares | 458,630 | 451,142 | 445,533 | 438,193 | 434,460 |
| Retained earnings | -504,965 | -490,565 | -484,400 | -477,713 | -469,696 |
| Other shareholders' equity | 789 | 720 | 958 | 961 | 653 |
| TOTAL | $115 | $6,089 | $6,494 | $5,983 | $9,057 |
| Total Liabilities And Equity | $15,057 | $19,974 | $19,702 | $20,187 | $24,262 |